BTG is proud to officially be a part of Boston Scientific BTG is a global healthcare company focused on Interventional Medicine. Our innovative medical technology helps physicians treat their patients through minimally invasive procedures. Today we have a growing portfolio of products that advance the treatment of cancer, vascular conditions and severe emphysema. Our Pharmaceuticals business provides products that help patients overexposed to certain medications or toxins. Our mission is to provide imaginative new ways to treat disease; making a real difference for patients, and a valuable contribution to healthcare. As medicine moves from major surgery to minor procedure, no company endeavours to do more to help doctors in their quest to see more, reach further and treat smarter. We understand their needs and equip them with tools and techniques that would have seemed like science fiction only a generation ago. We invest in clinical evidence that helps demonstrate the value of our treatments to patients, doctors, and healthcare systems. With relentless curiosity we’ll work with clinicians to find elegant new ways to extend our power over disease and transform patient care. There are no limits to where our ideas will take us.
View Top Employees from BTG plcWebsite | https://www.bostonscientific.com/en-US/medical-specialties/interventional-radiology/btg-joins-bsc.html |
Ticker | BTG |
Revenue | $837 million |
Employees | 691 (314 on RocketReach) |
Founded | 1948 |
Address | 300 Boston Scientific Way, Marlborough, Massachusetts 01752, US |
Phone | +44 20 7575 0000 |
Technologies |
JavaScript,
HTML,
PHP
+46 more
(view full list)
|
Industry | Medical Devices, Drug Manufacturing & Research, Biopharma, International Specialist Healthcare Company, Pharmaceuticals, Biotechnology, Interventional Oncology, Healthcare, Health Care, Specialty Pharmaceuticals, Medical Devices & Equipment, Science and Engineering, Interventional Vascular, Manufacturing, Emergency Medicine, Interventional Radiology, Test & Measurement Equipment, Medical, Interventional Pulmonology, Medical Testing & Clinical Laboratories, Pharmaceutical, Medical Device, Interventional Medicine |
Web Rank | 1 Million |
Keywords | Medical Technologies, Minimal Invasive Surgery, Cancer Treatment, Pharmaceuticals |
Competitors | Dexcel Pharma, OPKO Health, Inc., Sernova Corp., Swedish Orphan Biovitrum AB (Sobi), United Therapeutics Corporation |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 541 Companies |
Looking for a particular BTG plc employee's phone or email?
The BTG plc annual revenue was $837 million in 2024.
Sriram Srinivasan is the Senior Director Strategy and Business Development of BTG plc.
314 people are employed at BTG plc.
BTG plc is based in Marlborough, Massachusetts.
The NAICS codes for BTG plc are [325, 3254, 54, 5417, 32, 32541, 541].
The SIC codes for BTG plc are [283, 28].